JPMorgan Downgrades Array BioPharma (ARRY) to Neutral

February 3, 2017 6:37 AM EST Send to a Friend
JPMorgan downgraded Array BioPharma (NASDAQ: ARRY) from Overweight to Neutral ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login